LUM / Lumican, N-His, recombinant protein

Reference: PX-P5823-100
Product nameLUM / Lumican, N-His, recombinant protein
Origin speciesHomo sapiens (Human)
Expression systemProkaryotic expression
Molecular weight38.97 kDa
Protein delivered with Tag?N-terminal His Tag
Purity estimated>90% as determined by SDS-PAGE
BufferPBS, pH7.5
Delivery conditionDry Ice
Storage condition4°C for short term (1 week), -20°C or -80°C for long term (avoid freezing/thawing cycles; addition of 20-40% glycerol improves cryoprotection)
BrandProteoGenix
Host speciesEscherichia coli (E.coli)
ApplicationsELISA,WB
Fragment TypeGln19-Asn338
Protein AccessionP51884
ReferencePX-P5823
NoteFor research use only

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “LUM / Lumican, N-His, recombinant protein”

Your email address will not be published. Required fields are marked *

Related products

Durvalumab Biosimilar – Anti-PD-L1 mAb – Research Grade
Biosimilar

Durvalumab Biosimilar – Anti-PD-L1 mAb – Research Grade

PX-TA1002 300€
Avelumab Biosimilar – Anti-PD-L1 mAb – Research Grade
Biosimilar

Avelumab Biosimilar – Anti-PD-L1 mAb – Research Grade

PX-TA1003 300€
Nivolumab Biosimilar – Anti-PD1 mAb – Research Grade
Biosimilar

Nivolumab Biosimilar – Anti-PD1 mAb – Research Grade

PX-TA1004 300€
Utomilumab Biosimilar – Anti-Human TNFRSF9 mAb – Research Grade
Biosimilar

Utomilumab Biosimilar – Anti-Human TNFRSF9 mAb – Research Grade

PX-TA1012 400€
Sarilumab Biosimilar – Anti-IL-6R mAb – Research Grade
Biosimilar

Sarilumab Biosimilar – Anti-IL-6R mAb – Research Grade

PX-TA1028 300€
Lumiliximab Biosimilar – Anti-FCER2 mAb – Research Grade
Biosimilar

Lumiliximab Biosimilar – Anti-FCER2 mAb – Research Grade

PX-TA1114 400€
Stamulumab Biosimilar – Anti-MSTN, GDF-8 mAb – Research Grade
Biosimilar

Stamulumab Biosimilar – Anti-MSTN, GDF-8 mAb – Research Grade

PX-TA1144 400€
Camidanlumab Biosimilar – Anti-IL2RA, CD25 mAb – Research Grade
Biosimilar

Camidanlumab Biosimilar – Anti-IL2RA, CD25 mAb – Research Grade

PX-TA1163 400€
Tefibazumab Biosimilar – Anti-Fibrin-binding surface epitope clumping factor A mAb – Research Grade
Biosimilar

Tefibazumab Biosimilar – Anti-Fibrin-binding surface epitope clumping factor A mAb – Research Grade

PX-TA1187 400€
Foralumab Biosimilar – Anti-CD3E mAb – Research Grade
Biosimilar

Foralumab Biosimilar – Anti-CD3E mAb – Research Grade

PX-TA1245 400€
Oxelumab Biosimilar – Anti-TNFSF4, CD252 mAb – Research Grade
Biosimilar

Oxelumab Biosimilar – Anti-TNFSF4, CD252 mAb – Research Grade

PX-TA1248 400€
Carlumab Biosimilar – Anti-CCL2, MCP-1, MCAF, SCYA2 mAb – Research Grade
Biosimilar

Carlumab Biosimilar – Anti-CCL2, MCP-1, MCAF, SCYA2 mAb – Research Grade

PX-TA1252 400€
Namilumab Biosimilar – Anti-CSF2, GM-CSF mAb – Research Grade
Biosimilar

Namilumab Biosimilar – Anti-CSF2, GM-CSF mAb – Research Grade

PX-TA1259 400€
Urelumab Biosimilar – Anti-TNFRSF9, CD137  mAb – Research Grade
Biosimilar

Urelumab Biosimilar – Anti-TNFRSF9, CD137 mAb – Research Grade

PX-TA1265 400€
Stable Isotope Labeled Nivolumab Biosimilar – Anti-PD1 mAb – Research Grade
SIL

Stable Isotope Labeled Nivolumab Biosimilar – Anti-PD1 mAb – Research Grade

PX-TA1004-SIL 15000€

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.






    Cart (0 Items)

    Your cart is currently empty.

    View Products